100 related articles for article (PubMed ID: 19858393)
1. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
[TBL] [Abstract][Full Text] [Related]
2. Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.
Wang H; Liu YC; Zhu CY; Yan F; Wang MZ; Chen XS; Wang XK; Pang BX; Li YH; Liu DH; Gao CJ; Liu SJ; Dou LP
J Exp Clin Cancer Res; 2020 Dec; 39(1):278. PubMed ID: 33298132
[TBL] [Abstract][Full Text] [Related]
3. Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patients.
Wang YH; Orgueira AM; Lin CC; Yao CY; Lo MY; Tsai CH; de la Fuente Burguera A; Hou HA; Chou WC; Tien HF
Sci Rep; 2024 May; 14(1):11064. PubMed ID: 38744924
[TBL] [Abstract][Full Text] [Related]
4. Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.
Lamba JK; Crews KR; Pounds SB; Cao X; Gandhi V; Plunkett W; Razzouk BI; Lamba V; Baker SD; Raimondi SC; Campana D; Pui CH; Downing JR; Rubnitz JE; Ribeiro RC
Pharmacogenomics; 2011 Mar; 12(3):327-39. PubMed ID: 21449673
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic heterogeneity and the impact on cancer relapse.
Hassan C; Afshinnekoo E; Li S; Wu S; Mason CE
Exp Hematol; 2017 Oct; 54():26-30. PubMed ID: 28705639
[TBL] [Abstract][Full Text] [Related]
6. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.
Thein MS; Ershler WB; Jemal A; Yates JW; Baer MR
Cancer; 2013 Aug; 119(15):2720-7. PubMed ID: 23633441
[TBL] [Abstract][Full Text] [Related]
7. Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors.
Oswald LB; Venditti A; Cella D; Cottone F; Candoni A; Melillo L; Cairoli R; Storti G; Salutari P; Luppi M; Albano F; Martelli MP; Cuneo A; Tafuri A; Trisolini SM; Tieghi A; Fazi P; Vignetti M; Efficace F
BMJ Support Palliat Care; 2023 Dec; 13(e2):e344-e351. PubMed ID: 33941573
[TBL] [Abstract][Full Text] [Related]
8. DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.
Mishra SV; Banerjee A; Sarkar D; Thangarathnam V; Bagal B; Hasan SK; Dutt S
J Cell Sci; 2024 Feb; 137(3):. PubMed ID: 38240344
[TBL] [Abstract][Full Text] [Related]
9. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
Obermayer AN; Chang D; Nobles G; Teng M; Tan AC; Wang X; Chen YA; Eschrich S; Rodriguez PC; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw TI
BMC Bioinformatics; 2023 Jun; 24(1):266. PubMed ID: 37380943
[TBL] [Abstract][Full Text] [Related]
10. Itzykson R, Fournier E, Berthon C, et al. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021;138(7):507-519.
Blood; 2023 Jun; 141(26):3233. PubMed ID: 37383002
[No Abstract] [Full Text] [Related]
11. DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components.
Obermayer A; Chang D; Nobles G; Teng M; Tan AC; Wang X; Eschrich S; Rodriguez P; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw T
Res Sq; 2023 Mar; ():. PubMed ID: 36993526
[TBL] [Abstract][Full Text] [Related]
12. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Acute Myeloid Leukemia in Older Adults.
Alsouqi A; Geramita E; Im A
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001669
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and inflammatory markers in older adults with cancer: A Young International Society of Geriatric Oncology narrative review.
Gilmore N; Loh KP; Liposits G; Arora SP; Vertino P; Janelsins M
J Geriatr Oncol; 2024 Jan; 15(1):101655. PubMed ID: 37931584
[TBL] [Abstract][Full Text] [Related]
15. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed.
Walia A; Tuia J; Prasad V
Nat Rev Clin Oncol; 2023 Dec; 20(12):885-895. PubMed ID: 37828154
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes.
Ke P; Zhu Q; Xu T; Yang X; Wang Y; Qiu H; Wu D; Bao X; Chen S
Aging (Albany NY); 2023 Jun; 15(12):5826-5853. PubMed ID: 37367950
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine.
Kim M; Kim T; Ahn SY; Lee JH; Park JH; Shin MG; Jung SH; Song GY; Yang DH; Lee JJ; Choi SH; Kim MY; Ahn JS; Kim HJ; Kim DDH
Korean J Intern Med; 2023 Jul; 38(4):534-545. PubMed ID: 37291838
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of carbonic anhydrase 9 (CA9) in
Alyaqubi KJ; Dosh RH; Al-Fatlawi RB; Al-Rehemi SM; Hadi NR
J Med Life; 2022 Sep; 15(9):1158-1163. PubMed ID: 36415514
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation.
Yeaton A; Cayanan G; Loghavi S; Dolgalev I; Leddin EM; Loo CE; Torabifard H; Nicolet D; Wang J; Corrigan K; Paraskevopoulou V; Starczynowski DT; Wang E; Abdel-Wahab O; Viny AD; Stone RM; Byrd JC; Guryanova OA; Kohli RM; Cisneros GA; Tsirigos A; Eisfeld AK; Aifantis I; Guillamot M
Cancer Discov; 2022 Oct; 12(10):2392-2413. PubMed ID: 35924979
[TBL] [Abstract][Full Text] [Related]
20. A novel event-free survival endpoint in locally advanced pancreatic cancer.
Hammel P; Carrier E; Carney M; Eisner M; Fleming T
Ther Adv Med Oncol; 2021; 13():17588359211059586. PubMed ID: 34868352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
